RN7SL861P

Across TCGA pan-cancer cohorts, RN7SL861P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL861P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RN7SL861P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL861P is over-expressed in tumor.

BLCA, KIRC, and LUAD are the cancer types where RN7SL861P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL861P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	III,IV	+0.210	.030	3	view →
KIRC	Male	All	+0.039	.024	2	view →
LUAD	All	All	+0.131	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL861P–BLCA

Open the BLCA breakdown →